Zobrazeno 1 - 10
of 233
pro vyhledávání: '"Sollinger S"'
Autor:
Levsen, K., Sollinger, S.
A climate test chamber of 1 m3 volume for the determination of the emission of volatile organic compounds (VOCs) from building materials is presented. The chamber allows to vary the temperature and the relative humidity. It can be heated up to 200 C,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______610::892e653f06f20824b0e551376430d8d5
https://publica.fraunhofer.de/handle/publica/181878
https://publica.fraunhofer.de/handle/publica/181878
A method for the determination of organic acids in ambient air using an ion-exchange resin in a bifunctional manner is presented. The ion-exchange resin is used as an adsorbent for sampling and subsequently as catalyst for the methylation of the adso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______610::d205f4fb3758e3ed068c0a3d5389e628
https://publica.fraunhofer.de/handle/publica/181149
https://publica.fraunhofer.de/handle/publica/181149
During laser cutting of fibre-reinforced plastics (i.e. epoxy resins reinforced by aramide-, glass- or carbon fibres, phenol resins reinforced by aramide fibres, polyester, polyurethane and polyamide reinforced by glass fibres) mainly the same compou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______610::190a91cf4ae0ba3c46ee075d9e8dc899
https://publica.fraunhofer.de/handle/publica/180323
https://publica.fraunhofer.de/handle/publica/180323
Autor:
Paredes-Acuna, Natalia1 (AUTHOR) natalia.paredes@tum.de, Utpadel-Fischler, Daniel2 (AUTHOR), Ding, Keqin3 (AUTHOR), Thakor, Nitish V.3 (AUTHOR), Cheng, Gordon1 (AUTHOR)
Publikováno v:
Journal of NeuroEngineering & Rehabilitation (JNER). 1/13/2024, Vol. 21 Issue 1, p1-17. 17p.
Autor:
Godinho C; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, Lisboa, 1649-028, Portugal.; Instituto Superior de Ciências da Saúde Egas Moniz, Center for Interdisciplinary Research Egas Moniz (CiiEM), Monte de Caparica, Portugal.; CNS-Campus Neurológico Sénior, Torres Vedras, Portugal., Domingos J; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, Lisboa, 1649-028, Portugal.; CNS-Campus Neurológico Sénior, Torres Vedras, Portugal., Cunha G; Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, Lisbon, Portugal., Santos AT; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, Lisboa, 1649-028, Portugal., Fernandes RM; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, Lisboa, 1649-028, Portugal.; Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, Lisbon, Portugal., Abreu D; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, Lisboa, 1649-028, Portugal., Gonçalves N; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, Lisboa, 1649-028, Portugal., Matthews H; The Cure Parkinson's Trust, London, UK., Isaacs T; The Cure Parkinson's Trust, London, UK., Duffen J; The Cure Parkinson's Trust, London, UK., Al-Jawad A; HSG-IMIT, Villingen-Schwenningen, Germany., Larsen F; Norwegian Centre for Telemedicine, Tromso, Norway., Serrano A; Norwegian Centre for Telemedicine, Tromso, Norway., Weber P; Hasomed GmbH, Magdeburg, Germany., Thoms A; Hasomed GmbH, Magdeburg, Germany., Sollinger S; AbilityNet, London, UK., Graessner H; Institute for Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany., Maetzler W; Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, Center of Neurology, University of Tuebingen, Tuebingen, Germany., Ferreira JJ; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, Lisboa, 1649-028, Portugal. joaquimjferreira@gmail.com.; Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, Lisbon, Portugal. joaquimjferreira@gmail.com.; CNS-Campus Neurológico Sénior, Torres Vedras, Portugal. joaquimjferreira@gmail.com.
Publikováno v:
Journal of neuroengineering and rehabilitation [J Neuroeng Rehabil] 2016 Aug 01; Vol. 13 (1), pp. 71. Date of Electronic Publication: 2016 Aug 01.
Autor:
Godinho C; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, 1649-028, Lisboa, Portugal.; Center for Interdisciplinary Research Egas Moniz (CiiEM), Instituto Superior de Ciências da Saúde Egas Moniz, Monte de Caparica, Portugal.; CNS-Campus Neurológico Sénior, Torres Vedras, Portugal., Domingos J; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, 1649-028, Lisboa, Portugal.; CNS-Campus Neurológico Sénior, Torres Vedras, Portugal., Cunha G; Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, Lisbon, Portugal., Santos AT; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, 1649-028, Lisboa, Portugal., Fernandes RM; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, 1649-028, Lisboa, Portugal.; Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, Lisbon, Portugal., Abreu D; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, 1649-028, Lisboa, Portugal., Gonçalves N; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, 1649-028, Lisboa, Portugal., Matthews H; The Cure Parkinson's Trust, London, UK., Isaacs T; The Cure Parkinson's Trust, London, UK., Duffen J; The Cure Parkinson's Trust, London, UK., Al-Jawad A; HSG-IMIT, Villingen-Schwenningen, Germany., Larsen F; Norwegian Centre for Telemedicine, Tromso, Norway., Serrano A; Norwegian Centre for Telemedicine, Tromso, Norway., Weber P; Hasomed GmbH, Magdeburg, Germany., Thoms A; Hasomed GmbH, Magdeburg, Germany., Sollinger S; AbilityNet, London, UK., Graessner H; Institute for Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany., Maetzler W; Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, Center of Neurology, University of Tuebingen, Tuebingen, Germany., Ferreira JJ; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, 1649-028, Lisboa, Portugal. joaquimjferreira@gmail.com.; Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, Lisbon, Portugal. joaquimjferreira@gmail.com.; CNS-Campus Neurológico Sénior, Torres Vedras, Portugal. joaquimjferreira@gmail.com.
Publikováno v:
Journal of neuroengineering and rehabilitation [J Neuroeng Rehabil] 2016 Mar 12; Vol. 13, pp. 24. Date of Electronic Publication: 2016 Mar 12.
Autor:
Ferreira JJ; Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal. cgcgodinho@gmail.com.; Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, Lisbon, Portugal. cgcgodinho@gmail.com.; CNS - Campus Neurológico Sénior, Torres Vedras, Portugal. cgcgodinho@gmail.com., Godinho C; Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal. cgcgodinho@gmail.com.; CNS - Campus Neurológico Sénior, Torres Vedras, Portugal. cgcgodinho@gmail.com.; Center for Interdisciplinary Research Egas Moniz (CiiEM), Cooperativa de Ensino Superior Egas Moniz, Monte de Caparica, Caparica, Portugal. cgcgodinho@gmail.com., Santos AT; Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal. aa.teresa.ss@gmail.com., Domingos J; Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal. domingosjosefa@gmail.com., Abreu D; Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal. daideabreu@gmail.com., Lobo R; Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal. raquel.jl.lobo@gmail.com., Gonçalves N; Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal. nilzakarina@gmail.com., Barra M; Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal. marciocbarra@gmail.com., Larsen F; NST-Norwegian Centre for Integrated Care and Telemedicine, University Hospital North Norway, Tromsø, Norway. Frank.Larsen@telemed.no., Fagerbakke Ø; NST-Norwegian Centre for Integrated Care and Telemedicine, University Hospital North Norway, Tromsø, Norway. oyvind.fagerbakke@framhelse.no., Akeren I; NST-Norwegian Centre for Integrated Care and Telemedicine, University Hospital North Norway, Tromsø, Norway. ingvild.akeren@framhelse.no., Wangen H; NST-Norwegian Centre for Integrated Care and Telemedicine, University Hospital North Norway, Tromsø, Norway. Hilde.wangen@framhelse.no., Serrano JA; NST-Norwegian Centre for Integrated Care and Telemedicine, University Hospital North Norway, Tromsø, Norway. jarturserrano@gmail.com.; Department of Clinical Medicine, Faculty of Health Sciences, The Arctic University of Norway, Tromsø, Norway. jarturserrano@gmail.com., Weber P; Hasomed GmbH, Magdeburg, Germany. weber.peter@hasomed.de., Thoms A; Hasomed GmbH, Magdeburg, Germany. andrea.thoms@hasomed.de., Meckler S; HSG-IMIT, Villingen-Schwenningen, Germany. stefan.meckler@hsg-imit.de., Sollinger S; AbilityNet, London, UK. stefan.sollinger@abilitynet.org.uk., van Uem J; Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, Center of Neurology, University of Tuebingen, Tuebingen, Germany. janetvanuem@gmail.com.; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. janetvanuem@gmail.com., Hobert MA; Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, Center of Neurology, University of Tuebingen, Tuebingen, Germany. markus.hobert@med.uni-tuebingen.de.; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. markus.hobert@med.uni-tuebingen.de., Maier KS; Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, Center of Neurology, University of Tuebingen, Tuebingen, Germany. katrin-simone.maier@student.uni-tuebingen.de.; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. katrin-simone.maier@student.uni-tuebingen.de., Matthew H; The Cure Parkinson's Trust, London, UK. helen@cureparkinsons.org.uk., Isaacs T; The Cure Parkinson's Trust, London, UK. tom@cureparkinsons.org.uk., Duffen J; The Cure Parkinson's Trust, London, UK. joy@cureparkinsons.org.uk., Graessner H; Institute for Medical Genetics and Applied Genomics, University of Tübingen, Tuebingen, Germany. holm.graessner@med.uni-tuebingen.de., Maetzler W; Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, Center of Neurology, University of Tuebingen, Tuebingen, Germany. walter.maetzler@uni-tuebingen.de.; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. walter.maetzler@uni-tuebingen.de.
Publikováno v:
BMC neurology [BMC Neurol] 2015 Jun 10; Vol. 15, pp. 89. Date of Electronic Publication: 2015 Jun 10.
Autor:
Ferreira JJ; Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal.; Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, Portugal., Santos AT; Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal., Domingos J; Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal., Matthews H; The Cure Parkinson's Trust, London, UK., Isaacs T; The Cure Parkinson's Trust, London, UK., Duffen J; The Cure Parkinson's Trust, London, UK., Al-Jawad A; HSG-IMIT, Villingen-Schwenningen, Germany., Larsen F; NST-Norwegian Centre for Integrated Care and Telemedicine, University Hospital North Norway, Tromsø, Norway., Artur Serrano J; NST-Norwegian Centre for Integrated Care and Telemedicine, University Hospital North Norway, Tromsø, Norway.; Department of Clinical Medicine, Faculty of Health Sciences, The Arctic University of Norway, Tromsø, Norway., Weber P; Hasomed GmbH, Magdeburg, Germany., Thoms A; Hasomed GmbH, Magdeburg, Germany., Sollinger S; AbilityNet, London, UK., Graessner H; Institute for Medical Genetics and Applied Genomics, University of Tübingen, Germany., Maetzler W; Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, Center of Neurology, University of Tuebingen, Tuebingen, Germany.
Publikováno v:
Journal of Parkinson's disease [J Parkinsons Dis] 2015; Vol. 5 (2), pp. 281-90.
Autor:
Sollinger, S., Diamantoglou, M.
Publikováno v:
Journal of Raman Spectroscopy; Oct1997, Vol. 28 Issue 10, p811-817, 7p
Publikováno v:
Canadian Journal of Chemical Engineering; Dec1991, Vol. 69 Issue 6, p1247-1256, 10p